long term use of glp 1 agonists effects Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Can one drug do it

Trends in peptide drug discovery

Over the past several years, GLP-1 agonist weight-loss drugs have evolved from a celebrity trend to arguably the hottest growth opportunity in the pharmaceutical industry

PM: Curcumin 500mg + Probiotics Loading Phase: Week 1 at half-dose to assess tolerance, then increase gradually

Until more research is available, the use of these drugs in T1D should be done carefully, with a thorough discussion with patients about potential risks and benefits of this approach

This drop-off may be attributed to a subset of patientsoften impulse buyersseeking rapid weight loss rather than committing to long-term therapeutic regimens

The advancement of economical manufacturing procedures and biosimilars is an urgent need